The effects of drugs on embryonic development

Area of Science:

• Toxicology
• Developmental Biology
• Pharmacology

Background:

• Evaluating drug teratogenicity in humans is difficult due to limitations of epidemiologic studies and animal models.
• Current methods for predicting teratogenic effects are insufficient, necessitating the development of alternative approaches.
• Understanding the mechanisms of teratogenesis is crucial for developing predictive techniques.

Purpose of the Study:

• To investigate a potential mechanism of teratogenesis by examining embryonic oxidative metabolism.
• To explore the utility of measuring oxygen consumption in predicting drug-induced developmental abnormalities.
• To identify novel methods for assessing the teratogenic potential of chemical agents.

Main Methods:

• Inducing teratogenicity in pregnant rats using folic acid deficiency and antagonism with 9-methyl pteroylglutamic acid.
• Administering vitamin A acetate to pregnant rats and diphenylhydantoin to pregnant mice to induce malformations.
• Measuring and comparing oxygen consumption rates in normal versus abnormally developing embryos.

Main Results:

• Embryos exposed to teratogenic folic acid deficiency exhibited significantly decreased oxygen consumption.
• Rat embryos exposed to vitamin A acetate and mouse embryos exposed to diphenylhydantoin also showed reduced oxygen consumption.
• A correlation was observed between teratogenic exposure, abnormal embryonic development, and diminished oxidative metabolism.

Conclusions:

• Measurements of embryonic oxidative metabolism may serve as a predictive tool for drug teratogenicity.
• This approach could complement existing epidemiologic and empirical methods for identifying human teratogens.
• Further research into metabolic indicators could enhance the safety assessment of drugs during pregnancy.